Investing Profile

Peter Bisgaard

InvestorVC
Managing Director at Pivotal bioVenture Partners
pivotalbiovp.com/team-members...San Francisco Bay Area
Photo of Peter Bisgaard, Managing Director at Pivotal bioVenture Partners
Your Intro Paths to Peter Bisgaard

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Peter Bisgaard on

cb
Current Investing Position
Pivotal bioVenture Partners Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
20
Current Fund Size
$300M

Peter Bisgaard is on these Sector & Stage Rankings

Peter Bisgaard's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Addition Therapeutics
Series ADec 2025$100M
$100M
Co-investors: Jayson Punwani (Abingworth), Jennifer Lee (Pivotal bioVenture Partners)
Engrail Therapeutics
Series BMar 2024$160M
Series AAug 2021$32M
Series AJun 2020$32M
$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital), Jasper Bos (Forbion)
Oculis
Series CMay 2021$57M
Series BJan 2019$16M
$190M
Co-investors: Rob Hopfner (Pivotal bioVenture Partners), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Eargo
Series EJul 2020$82M
Series DMar 2019$52M
Series COct 2017$45M
$220M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), David Wu (Maveron LLC), Dan Levitan (Maveron), Juliet Tammenoms Bakker (Longitude Capital), Ben Capell (Peterson Ventures), Pierre Lamond (Eclipse Ventures), Farzad Nazem
OncXerna Therapeutics
Series BJun 2019$80M
$80M
Ceterix Orthopaedics
Series BMay 2014$18M
$18M
Co-investors: Charles Warden (Versant Ventures)
Otonomy
Series DApr 2014$49M
Series CSep 2013$46M
Series BAug 2010$39M
Series BAug 2010$39M
$180M
Co-investors: Chau Khuong (OrbiMed), Brian Dovey (Domain Associates), John McKearn (RiverVest), Niall O’Donnell (RiverVest), Jay Lichter (Avalon Ventures), Bill Harrington (Osage University Partners), Heather Preston
Nevro
Series CMar 2013$48M
$130M
Co-investors: Asish Xavier (Johnson & Johnson Innovation), Paul Klingenstein (Aberdare Ventures)

Peter Bisgaard's Experience

Managing Director Nan Fung Life Sciences2017 - Present

Founders who looked at Peter Bisgaard's profile also looked at these Scouts & Angels

Photo of Justin Waldron, Angel

Photo of Brad Holden, Managing Partner

Photo of Errol Damelin, Angel

Photo of Alexandra Cox-Cuzzi